Rafke Schoffelen

Androgen Receptor–Positive Salivary Duct Carcinoma: A Disease Entity With Promising New Treatment Options

Heidy C.J. Jaspers, Berit M. Verbist, Rafke Schoffelen et al. · Journal of Clinical Oncology · 2011 · 178 citations · Full text

Disease Entity, Endocrine-related Cancer, Medicine +8

Pretargeted Immuno–Positron Emission Tomography Imaging of Carcinoembryonic Antigen–Expressing Tumors with a Bispecific Antibody and a 68Ga- and 18F-Labeled Hapten Peptide in Mice with Human Tumor Xenografts

Rafke Schoffelen, Robert M. Sharkey, David M. Goldenberg et al. · Molecular Cancer Therapeutics · 2010 · 99 citations · Full text

Immunocytochemical Technique, Engineering, Oncologic Imaging +21

Development of an imaging-guided CEA-pretargeted radionuclide treatment of advanced colorectal cancer: first clinical results

Rafke Schoffelen, Otto C. Boerman, David M. Goldenberg et al. · British Journal of Cancer · 2013 · 85 citations · Full text

Pretargeted ¹⁷⁷Lu Radioimmunotherapy of Carcinoembryonic Antigen–Expressing Human Colonic Tumors in Mice

Rafke Schoffelen, Winette T.A. van der Graaf, Gerben M. Franssen et al. · Journal of Nuclear Medicine · 2010 · 48 citations · Full text

Multiparameter flow cytometry as a tool for the detection of micrometastatic tumour cells in the sentinel lymph node procedure of patients with breast cancer

Mathie P.G. Leers, Rafke Schoffelen, Jennifer Hoop et al. · Journal of Clinical Pathology · 2002 · 44 citations